-
Calliditas Therapeutics announces positive phase 2b data in Primary Biliary Cholangitis trial
Source: Pharmafile Published on 2024-07-26
-
AC Immune’s pTau-targeting immunotherapy awarded Fast Track designation by FDA
Source: Pharmafile Published on 2024-07-26
-
BioAtla gains FDA Fast Track Designation for ozuriftamab vedotin
Source: Pharmafile Published on 2024-07-25
-
Eisai and EcoNaviSta enter dementia collaboration
Source: Pharmafile Published on 2024-07-25
-
Agilent to acquire BIOVECTRA for $925m
Source: Pharmafile Published on 2024-07-24
-
J&J seeks FDA approval of Spravato as monotherapy for treatment-resistant depression
Source: Pharmafile Published on 2024-07-24
-
ViiV Healthcare shares data for two-drug regimen for HIV-1 maintenance therapy
Source: Pharmafile Published on 2024-07-23
-
ViroCell Biologics signs Master Services Agreement with NCI-designated cancer centre
Source: Pharmafile Published on 2024-07-23
-
60 Degrees Pharmaceuticals signs clinical trial agreements with sites for babesiosis study
Source: Pharmafile Published on 2024-07-22
-
Results from Sanofi’s ALTUVIIIO XTEND-Kids phase 3 trial published in NEJM
Source: Pharmafile Published on 2024-07-22
-
GSK’s application for Blenrep for MM treatment accepted for EMA review
Source: Pharmafile Published on 2024-07-19
-
Brainomix and Boehringer Ingelheim enter strategic partnership
Source: Pharmafile Published on 2024-07-19
-
FDA accepts Atara Biotherapeutics’ Tab-Cel for priority review
Source: Pharmafile Published on 2024-07-18
-
China’s NMPA accepts Everest Medicines’ Nefecon supplementary application
Source: Pharmafile Published on 2024-07-18
-
Loci Orthopaedics announces €12.8m series A financing
Source: Pharmafile Published on 2024-07-17